RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to $142.00. The firm maintained a Sector Perform rating on the stock. The upgrade comes as Morgan Stanley's stock trades near its 52-week high of $136.

In a report released on January 21, Richard Chamberlain from RBC Capital maintained a Buy rating on Next plc (NXT – Research Report), with a

RBC Capital analyst Brian Abrahams maintained a Buy rating on Regeneron (REGN – Research Report) on January 21 and set a price target of

Morgan Stanley's profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove its revenue to a full-year record.

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, National Bank economist Warren Lovely noted the important fact that global interest in Canadian bonds remains high,

“We think Morgan Stanley benefits from favorable secular trends in the capital markets, wealth management, and investment banking,” he said in a research note. Morgan Stanley’s revenue from ...

Daniel Fannon; Analyst; Jefferies & Company Inc. Gerard Cassidy; Analyst; RBC Capital Markets

RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on the stock to $132 from the previous $108.

The round, which values Databricks at $US62 billion, was led by Temasek, Macquarie Capital and Qatar’s sovereign wealth fund QIA. Meta also joined as a strategic investor.

In a report released on January 20, Rishi Jaluria from RBC Capital maintained a Buy rating on Clearwater Analytics Holdings (CWAN – Research

Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $14.55 which represents a slight increase of $0.42 or 2.97% from the prior close of $14.13. The stock opened at $14.3 and touched a low of $13.

Hedge funds have positioned for Donald Trump's U.S. presidency with their highest levels of borrowing since 2010, while betting the dollar would continue to rise, according to bank research and industry data.